Willingness to Co-receive COVID-19 and Influenza Vaccines among Outpatients

IF 4.6 Q2 MATERIALS SCIENCE, BIOMATERIALS ACS Applied Bio Materials Pub Date : 2023-08-30 DOI:10.5993/ajhb.47.4.8
Krissy Moehling Geffel, Mary Patricia Nowalk, Theresa M. Sax, Louise Taylor, Karen Clarke, Michael Susick, G.K. Balasubramani, Richard K. Zimmerman
{"title":"Willingness to Co-receive COVID-19 and Influenza Vaccines among Outpatients","authors":"Krissy Moehling Geffel, Mary Patricia Nowalk, Theresa M. Sax, Louise Taylor, Karen Clarke, Michael Susick, G.K. Balasubramani, Richard K. Zimmerman","doi":"10.5993/ajhb.47.4.8","DOIUrl":null,"url":null,"abstract":"Objectives: This study was designed to examine future willingness to co-receive COVID-19 and influenza vaccines and factors associated with that willingness among outpatients with acute respiratory illness (ARI). Methods: Outpatients ≥15 years with respiratory symptoms for ≤10 days were surveyed about vaccination behaviors and intentions. We used multinomial logistic regression to assess associations between demographic, behavioral and health-related variables and willingness to co-receive future COVID-19 and influenza vaccines. Results: Among 856 patients, 41% had received ≥1 COVID-19 vaccines plus booster and 42% had received seasonal influenza vaccine; 47% reported willingness to co-receive COVID-19 and influenza vaccines with 25% unsure and 28% unwilling. Higher educational attainment (OR=1.80, p=.009), receipt of ≥1 COVID-19 vaccines (OR=4.29, p<.001), greater 5-year influenza vaccine uptake (annually OR=8.54, p<.001; sometimes OR=5.38, p<.001) and lower likelihood of testing COVID-19 positive (OR=0.68, p=.033) were significantly associated with willingness to co-receive compared to those decidedly opposed. Conclusions: Prior vaccination behavior predicted willingness to co-receive future COVID-19 and influenza vaccines. Efforts to encourage co-receipt are more likely to succeed among routine vaccine recipients. Vaccination promotion efforts for those hesitant or unwilling to co-receive these vaccines may need to focus on improving uptake of each vaccine individually.","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2023-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5993/ajhb.47.4.8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: This study was designed to examine future willingness to co-receive COVID-19 and influenza vaccines and factors associated with that willingness among outpatients with acute respiratory illness (ARI). Methods: Outpatients ≥15 years with respiratory symptoms for ≤10 days were surveyed about vaccination behaviors and intentions. We used multinomial logistic regression to assess associations between demographic, behavioral and health-related variables and willingness to co-receive future COVID-19 and influenza vaccines. Results: Among 856 patients, 41% had received ≥1 COVID-19 vaccines plus booster and 42% had received seasonal influenza vaccine; 47% reported willingness to co-receive COVID-19 and influenza vaccines with 25% unsure and 28% unwilling. Higher educational attainment (OR=1.80, p=.009), receipt of ≥1 COVID-19 vaccines (OR=4.29, p<.001), greater 5-year influenza vaccine uptake (annually OR=8.54, p<.001; sometimes OR=5.38, p<.001) and lower likelihood of testing COVID-19 positive (OR=0.68, p=.033) were significantly associated with willingness to co-receive compared to those decidedly opposed. Conclusions: Prior vaccination behavior predicted willingness to co-receive future COVID-19 and influenza vaccines. Efforts to encourage co-receipt are more likely to succeed among routine vaccine recipients. Vaccination promotion efforts for those hesitant or unwilling to co-receive these vaccines may need to focus on improving uptake of each vaccine individually.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
门诊患者联合接种COVID-19和流感疫苗的意愿
目的:本研究旨在调查急性呼吸道疾病(ARI)门诊患者未来联合接种COVID-19和流感疫苗的意愿以及与此意愿相关的因素。方法:对年龄≥15岁且呼吸道症状持续≤10天的门诊患者进行疫苗接种行为和意向调查。我们使用多项逻辑回归来评估人口统计学、行为和健康相关变量与共同接受未来COVID-19和流感疫苗的意愿之间的关联。结果:856例患者中,41%接种了≥1种COVID-19疫苗加强化疫苗,42%接种了季节性流感疫苗;47%的人表示愿意同时接种COVID-19和流感疫苗,25%的人不确定,28%的人不愿意。较高的受教育程度(OR=1.80, p= 0.009)、接种≥1支COVID-19疫苗(OR=4.29, p= 0.001)、较高的5年流感疫苗接种率(OR= 8.54, p= 0.001;有时OR=5.38, p= 0.001)和较低的COVID-19检测阳性的可能性(OR=0.68, p= 0.033)与坚决反对的患者相比,与共同接受意愿显著相关。结论:既往疫苗接种行为可预测未来联合接种COVID-19和流感疫苗的意愿。鼓励共同接种的努力更有可能在常规疫苗接受者中取得成功。对于那些犹豫不决或不愿共同接种这些疫苗的人,疫苗接种促进工作可能需要侧重于提高每种疫苗的吸收率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
ACS Applied Bio Materials
ACS Applied Bio Materials Chemistry-Chemistry (all)
CiteScore
9.40
自引率
2.10%
发文量
464
期刊最新文献
A Systematic Review of Sleep Disturbance in Idiopathic Intracranial Hypertension. Advancing Patient Education in Idiopathic Intracranial Hypertension: The Promise of Large Language Models. Anti-Myelin-Associated Glycoprotein Neuropathy: Recent Developments. Approach to Managing the Initial Presentation of Multiple Sclerosis: A Worldwide Practice Survey. Association Between LACE+ Index Risk Category and 90-Day Mortality After Stroke.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1